Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and overtime? A pooled analysis of 610 RCTs published between 2004 and 2018 Meeting Abstract


Authors: Sparano, F.; Aaronson, N. K.; Sprangers, M. A. G.; Fayers, P.; Pusic, A.; Kieffer, J. M.; Rees, J.; Wan, C. H.; Pezold, M.; Fuzesi, S.; Isharwal, S.; Anota, A.; Charton, E.; Vignetti, M.; Cottone, F.; Blazeby, J. M.; Efficace, F.
Abstract Title: Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and overtime? A pooled analysis of 610 RCTs published between 2004 and 2018
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Language: English
ACCESSION: WOS:000487345802176
DOI: 10.1200/JCO.2019.37.15_suppl.e18218
PROVIDER: wos
Notes: Meeting Abstract: e18218 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sarah Fuzesi
    18 Fuzesi
  2. Michael Leonce Pezold
    5 Pezold